Active ingredientCytarabineCat. No. P-C279-001CAS 147-94-4Family · Pharmaceutical analytical standards
Cytarabine
A nucleoside analogue of cytidine (cytosine arabinoside, ara-C) that blocks DNA synthesis: first synthesised in 1959 at the University of California, Berkeley, and approved in the United States in 1969, it is a mainstay of treatment for acute leukaemias. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It grew out of the study of two unusual nucleosides containing the sugar arabinose, isolated in the 1950s from the Caribbean sponge Tectitethya crypta.
Go to the active ingredient →Active ingredientCytarabineCat. No. P-C279-001CAS 147-94-4
Pharmacopoeial impurityCytarabine EP Impurity ACat. No. P-C279-002CAS 3083-77-0
Pharmacopoeial impurityCytarabine EP Impurity FCat. No. P-C279-003CAS 32830-01-6
Pharmacopoeial impurityCytarabine EP Impurity GCat. No. P-C279-004CAS 2140-61-6
Pharmacopoeial impurityCytarabine EP Impurity ICat. No. P-C279-005CAS 6829-31-8
Isotopically labelledCytarabine-13C-15N2Cat. No. P-C279-007
Isotopically labelledCytarabine-13C3Cat. No. P-C279-008
ImpurityCytarabine Impurity 1Cat. No. P-C279-009CAS 14057-18-2
Impurity1-Alpha-L-RibofuranosylcytosineCat. No. P-C279-010CAS 179239-81-7
ImpurityCytarabine Impurity 2Cat. No. P-C279-011CAS 7428-39-9
ImpurityCytarabine Impurity 3Cat. No. P-C279-012CAS 13913-16-1
ImpurityCytarabine Impurity 4Cat. No. P-C279-013CAS 84902-98-7
ImpurityCytarabine Impurity 5Cat. No. P-C279-014
ImpurityCytarabine Impurity 6Cat. No. P-C279-016CAS 30902-36-4
ImpurityCytarabine Impurity 7Cat. No. P-C279-017CAS 58461-29-3
ImpurityCytarabine Impurity 8Cat. No. P-C279-018
ImpurityCytarabine Impurity 9Cat. No. P-C279-019
ImpurityCytarabine Impurity 10Cat. No. P-C279-020CAS 69321-95-5
ImpurityCytarabine Impurity 11Cat. No. P-C279-021CAS 3310-47-2
ImpurityCytarabine Impurity 12Cat. No. P-C279-022
ImpurityCytarabine Impurity 13Cat. No. P-C279-023
ImpurityCytarabine Impurity 14Cat. No. P-C279-024
ImpurityCytarabine Impurity 15Cat. No. P-C279-025
ImpurityCytarabine Impurity 16Cat. No. P-C279-026
ImpurityCytarabine Impurity 17Cat. No. P-C279-027
ImpurityCytarabine Impurity 18Cat. No. P-C279-028
ImpurityCytarabine Impurity 19Cat. No. P-C279-029
ImpurityCytarabine Impurity 20Cat. No. P-C279-030
ImpurityCytarabine Impurity 21Cat. No. P-C279-031CAS 82855-62-7
ImpurityCytarabine Impurity 22Cat. No. P-C279-032
ImpurityCytarabine Impurity 23Cat. No. P-C279-033
ImpurityCytarabine Impurity 24Cat. No. P-C279-034
ImpurityCytarabine Impurity 25Cat. No. P-C279-035
ImpurityCytarabine Impurity 26Cat. No. P-C279-036
ImpurityCytarabine Impurity 27Cat. No. P-C279-037
ImpurityCytarabine Impurity 28Cat. No. P-C279-038CAS 69260-69-1
ImpurityCytarabine Impurity 29Cat. No. P-C279-039
ImpurityCytarabine Impurity 30Cat. No. P-C279-040
ImpurityCytarabine MonophosphateCat. No. P-C279-041CAS 7075-11-8
ImpurityDeoxy ChlorocytarabineCat. No. P-C279-042CAS 32659-31-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceCytarabine CRSEDQM code C3350000Family CytarabineReference substanceUracil arabinoside CRSEDQM code U0100000Family CytarabineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.